Bayesian Capital Management »

Fate Therapeutics shares owned by Bayesian Capital Management

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Bayesian Capital Management from 13F filings

Historical chart of Bayesian Capital Management investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Bayesian Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Bayesian Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $292k 40k 7.34
2023-12-31 $73k 20k 3.74
2023-09-30 $81k 38k 2.12
2023-06-30 $287k 60k 4.76
2023-03-31 $162k 28k 5.70
2022-12-31 $189k 19k 10.09
2022-09-30 $332k 15k 22.38
2021-03-31 $519k 6.3k 82.38